KalVista Pharmaceuticals Inc (KALV)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$16.89

Buy

$17.25

arrow-up$0.01 (+0.06%)

Prices updated at 13 Dec 2025, 00:27 EST

Prices minimum 15 mins delay

Prices in USD

KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$17.15 - $16.40
	$17.28 - $7.30
	-
	854.74m
	-
	-
	598,217
	50.28
	947,042.67
	-0.25
	49.76m
	US4834971032
	-3.94
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.